Longevity Biomedical (Longevity Biomedical) Total Payout Ratio : 0.00 (As of Jun. 14, 2024)

View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Longevity Biomedical's current Total Payout Ratio is 0.00.

Longevity Biomedical Total Payout Ratio Historical Data

The historical data trend for Longevity Biomedical's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical Total Payout Ratio Chart

Longevity Biomedical Annual Data

Trend

Total Payout Ratio

Longevity Biomedical Semi-Annual Data

Total Payout Ratio

Competitive Comparison of Longevity Biomedical's Total Payout Ratio

For the Biotechnology subindustry, Longevity Biomedical's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Longevity Biomedical's Total Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longevity Biomedical's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Longevity Biomedical's Total Payout Ratio falls into.

Longevity Biomedical Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Longevity Biomedical's Total Payout Ratio for the fiscal year that ended in . 20 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (	+		+	)	/
	=	N/A

Longevity Biomedical's Total Payout Ratio for the quarter that ended in . 20 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (	+		+	)	/
	=	N/A

Longevity Biomedical Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Longevity Biomedical (Longevity Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Total Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011

Website

https://www.longevitybiomedical.com

Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines